{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-308794","form_type":"8-K","ticker":"XOMA","cik":"0000791908","company_name":"XOMA Royalty Corp","filed_at":"2025-12-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.174602+00:00","generated_at":"2026-05-16T14:25:38.084517+00:00","sec_items":["2.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"XOMA Royalty completes acquisition of Mural Oncology for $2.035/share","bullets":["Deal closed Dec 5, 2025; Mural shareholders received $2.035 cash per share.","Transaction approved by Mural shareholders on Oct 24, 2025; Irish High Court sanctioned Dec 3.","Mural shares ceased trading on Nasdaq effective Dec 5; will be delisted and deregistered.","XOMA Royalty acquired entire share capital of Mural via Irish scheme of arrangement."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-308794","json":"https://secwatch.observer/filing/0001193125-25-308794.json","markdown":"https://secwatch.observer/filing/0001193125-25-308794.md","text":"https://secwatch.observer/filing/0001193125-25-308794.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/791908/000119312525308794/0001193125-25-308794-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/791908/000119312525308794/d20776d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T14:25:38.084517+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}